MADRIGAL PHARMACEUTICALS, INC. (MDGL) /

The profitability of MADRIGAL PHARMACEUTICALS, INC. over the past 10 years

Chart MADRIGAL PHARMACEUTICALS, INC.: gross profit, operating income, net income, fiscal 2016–2025 Open the chart →

MADRIGAL PHARMACEUTICALS, INC. reported a net loss of $288.28M in fiscal 2025, the latest fiscal year on file. That year it had an operating loss of $300.1M. It reported a loss in all 10 years shown.

Year by year

Fiscal yearGross profitOperating incomeNet income
2025ended Dec 31, 2025—-$300.1M-$288.28M
2024ended Dec 31, 2024$173.9M*-$497.88M-$465.89M
2023ended Dec 31, 2023$0*-$380.5M-$373.63M
2022ended Dec 31, 2022$0*-$293.57M-$295.35M
2021ended Dec 31, 2021—-$242.48M-$241.85M
2020ended Dec 31, 2020—-$206.67M-$202.24M
2019ended Dec 31, 2019—-$94.97M-$83.95M
2018ended Dec 31, 2018—-$40.68M-$32.81M
2017ended Dec 31, 2017—-$32.06M-$31.15M
2016ended Dec 31, 2016—-$25.22M-$26.39M

Fiscal years as MADRIGAL PHARMACEUTICALS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.

More on MADRIGAL PHARMACEUTICALS, INC.

Companies of a similar size

Not investment advice. This page shows what MADRIGAL PHARMACEUTICALS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.